171 related articles for article (PubMed ID: 24102472)
1. Pathophysiology and pharmacologic treatment of venous thromboembolism.
Bain J; Oyler DR; Smyth SS; Macaulay TE
Curr Drug Targets; 2014 Feb; 15(2):199-209. PubMed ID: 24102472
[TBL] [Abstract][Full Text] [Related]
2. Benefit-risk profile of non-vitamin K antagonist oral anticoagulants in the management of venous thromboembolism.
Beyer-Westendorf J; Ageno W
Thromb Haemost; 2015 Feb; 113(2):231-46. PubMed ID: 25319150
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of direct oral anticoagulants for the treatment of cancer-associated thrombosis: an update.
Franco-Moreno A; Cabezón-Gutiérrez L; Palka-Kotlowsa M; Villamayor-Delgado M; García-Navarro M
J Thromb Thrombolysis; 2019 Apr; 47(3):409-419. PubMed ID: 30467760
[TBL] [Abstract][Full Text] [Related]
4. Advances in the management of venous thromboembolism.
Schulman S
Best Pract Res Clin Haematol; 2012 Sep; 25(3):361-77. PubMed ID: 22959552
[TBL] [Abstract][Full Text] [Related]
5. Use of the Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism.
Riva N; Ageno W
Hematol Oncol Clin North Am; 2016 Oct; 30(5):1035-51. PubMed ID: 27637306
[TBL] [Abstract][Full Text] [Related]
6. Current and emerging strategies in the management of venous thromboembolism: benefit-risk assessment of dabigatran.
Fanola CL
Vasc Health Risk Manag; 2015; 11():271-82. PubMed ID: 26064057
[TBL] [Abstract][Full Text] [Related]
7. New anticoagulants for the treatment of venous thromboembolism.
Prandoni P; Dalla Valle F; Piovella C; Tormene D; Pesavento R
Minerva Med; 2013 Apr; 104(2):131-39. PubMed ID: 23514989
[TBL] [Abstract][Full Text] [Related]
8. [New anticoagulants in the prevention and treatment of venous thromboembolism].
Keltai M; Keltai K
Orv Hetil; 2011 Jun; 152(25):983-92. PubMed ID: 21642050
[TBL] [Abstract][Full Text] [Related]
9. Factor Xa Inhibitors and Direct Thrombin Inhibitors Versus Low-Molecular-Weight Heparin for Thromboprophylaxis After Total Hip or Total Knee Arthroplasty: A Systematic Review and Meta-Analysis.
Sun G; Wu J; Wang Q; Liang Q; Jia J; Cheng K; Sun G; Wang Z
J Arthroplasty; 2019 Apr; 34(4):789-800.e6. PubMed ID: 30685261
[TBL] [Abstract][Full Text] [Related]
10. Direct Oral Anticoagulants: Overcoming the Challenges of Managing Venous Thromboembolism in Children.
Male C; Monagle P; Albisetti M; Brandão LR; Young G
J Pediatr; 2022 Jan; 240():14-23. PubMed ID: 34687696
[No Abstract] [Full Text] [Related]
11. The evolution of anticoagulant therapy.
Franchini M; Liumbruno GM; Bonfanti C; Lippi G
Blood Transfus; 2016 Mar; 14(2):175-84. PubMed ID: 26710352
[TBL] [Abstract][Full Text] [Related]
12. Using direct oral anticoagulants (DOACs) in cancer and other high-risk populations.
van Es N; Büller HR
Hematology Am Soc Hematol Educ Program; 2015; 2015():125-31. PubMed ID: 26637711
[TBL] [Abstract][Full Text] [Related]
13. Venous Thromboembolism in Children: From Diagnosis to Management.
Lassandro G; Palmieri VV; Palladino V; Amoruso A; Faienza MF; Giordano P
Int J Environ Res Public Health; 2020 Jul; 17(14):. PubMed ID: 32664502
[TBL] [Abstract][Full Text] [Related]
14. Direct inhibitors of coagulation proteins - the end of the heparin and low-molecular-weight heparin era for anticoagulant therapy?
Laux V; Perzborn E; Heitmeier S; von Degenfeld G; Dittrich-Wengenroth E; Buchmüller A; Gerdes C; Misselwitz F
Thromb Haemost; 2009 Nov; 102(5):892-9. PubMed ID: 19888525
[TBL] [Abstract][Full Text] [Related]
15. Current and emerging options in the management of venous thromboembolism.
Jaffer AK; Brotman DJ; Michota F
Cleve Clin J Med; 2005 Apr; 72 Suppl 1():S14-23. PubMed ID: 15853175
[TBL] [Abstract][Full Text] [Related]
16. Direct oral anticoagulants in patients with VTE and cancer: a systematic review and meta-analysis.
Vedovati MC; Germini F; Agnelli G; Becattini C
Chest; 2015 Feb; 147(2):475-483. PubMed ID: 25211264
[TBL] [Abstract][Full Text] [Related]
17. Venous thromboembolism management: where do novel anticoagulants fit?
Spyropoulos AC; Turpie AG
Curr Med Res Opin; 2013 Jul; 29(7):783-90. PubMed ID: 23659584
[TBL] [Abstract][Full Text] [Related]
18. Current concepts for the prevention of venous thromboembolism.
Bramlage P; Pittrow D; Kirch W
Eur J Clin Invest; 2005 Mar; 35 Suppl 1():4-11. PubMed ID: 15701142
[TBL] [Abstract][Full Text] [Related]
19. Acute phase treatment of VTE: Anticoagulation, including non-vitamin K antagonist oral anticoagulants.
Hillis C; Crowther MA
Thromb Haemost; 2015 Jun; 113(6):1193-202. PubMed ID: 25948149
[TBL] [Abstract][Full Text] [Related]
20. Profile of betrixaban and its potential in the prevention and treatment of venous thromboembolism.
Chan NC; Bhagirath V; Eikelboom JW
Vasc Health Risk Manag; 2015; 11():343-51. PubMed ID: 26170684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
